Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Circulating tumour cells

ECCO 15 - ESMO 34

Published: 3 Nov 2009

Views: 12613

Rating:

Save

Anieta Sieuwerts - Erasmus University Rotterdam

Discusses the research presented on circulating tumour cells at ECCO 15 - ESMO 34, Berlin 2009.

Categories:
Diagnostics

Related Videos

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )

Tele-mentoring: Impact of project ECHO

Dr Sanjeev Arora - Project ECHO, Albuquerque, USA

Tele-mentoring: Impact of project ECHO ( Dr Sanjeev Arora - Project ECHO, Albuquerque, USA )

Predicting tumour mutations from pathology images may help increase...

Dr Rom Leidner - Providence Cancer Institute, Portland, USA

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation ( Dr Rom Leidner - Providence Cancer Institute, Portland, USA )

Choosing the right patients for transplant

Dr Sameer Tulpule - Kokilaben Dhirubhai Ambani Hospital, Mumbai, India

Choosing the right patients for transplant ( Dr Sameer Tulpule - Kokilaben Dhirubhai Ambani Hospital, Mumbai, India )

Choosing Wisely in endometrial & cervix cancers: Medical therapy

Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India

Choosing Wisely in endometrial & cervix cancers: Medical therapy ( Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India )

Cancer mutation prediction using artificial intelligence

Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA

Cancer mutation prediction using artificial intelligence ( Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA )

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof...

ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )

Understanding patient factors and barriers in oncology treatment

Dr Prateek Jain - Tata Medical Center, Kolkata

Understanding patient factors and barriers in oncology treatment ( Dr Prateek Jain - Tata Medical Center, Kolkata )

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA

Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )

More from ecancer